AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04391023 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 4 mA Transcranial Direct Current Stimulation
Description: tDCS is a non-invasive brain stimulation technique in which very weak electrical current (4 mA) is applied to the scalp for 20 minutes. The anode and cathode will both be placed over the cerebellum.
Study NCT05172856 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IBI321
Description: IBI321 at a dose no higher than RP2D, D1 IV Q3W.
Study NCT05914662 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zanubrutinib, Bendamustine and Rituximab
Description: Zanubrutinib, 160mg orally, twice a day; Bendamustine 70 mg/m2 on days 1 and 2 of each cycle; Rituximab (375 mg/m2 intravenously on day 0 of each cycle. ZBR was administered every 4 weeks for a total of 6 cycles, followed by maintenance therapy with zanubrutinib monotherapy for another 6 months.
Study NCT05557162 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: AI ECG Amyloid algorithm
Description: Artificial intelligence enabled electrocardiogram screening tool used to identify the predictive model that best differentiates those at greatest risk for an amyloidosis diagnosis
Study NCT05757310 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Anti-Thymocyte Globulin
Description: Given IV
Study NCT05757310 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT05757310 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Aspirate
Description: Undergo bone marrow aspirate
Study NCT05757310 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Biopsy
Description: Undergo bone marrow biopsy
Study NCT05757310 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Given PO and IV
Study NCT05757310 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Haploidentical Hematopoietic Cell Transplantation
Description: Undergo CD4+ T-cell depleted haploHCT
Study NCT05757310 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pentostatin
Description: Given IV
Study NCT05757310 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT06238609 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Intervention Group
Description: Subjects will receive a functional neuromodulation device to wear for 1 hour daily up to four weeks or until hospital discharge, whichever came first.
Study NCT05452577 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Suanzaoren Decoction and Huanglian Wendan Decoction
Description: Twice daily. Chinese herbal medicine includes: includes: 25 grams of Suanzaoren, 10 grams of chuanxiong, 30 grams of fushen, 10 grams of Polygala tenuifolia, 10 grams of Pinellia ternata, 12 grams of tangerine peel, 15 grams of Zhuru, 30 grams of forged keel, 30 grams of forged oyster,10 grams of aurantii fructus, 6 grams of coptis chinensis, 30 grams of Albizzia bark.Add or subtract Chinese herbal medicine according to the different clinical manifestations of each patient.
Study NCT05452577 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Estazolam 1Mg Tab
Description: 1mg tablet once daily
Study NCT04980521 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The radon app
Description: Participants will be asked to use the radon app.
Study NCT05990088 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Heat Cured Conventional Polymethylmethacrylate Complete Removable Dentures based on neutral zone concept
Description: The patients will receive complete removable dentures designed based on neutral zone concept and manufactured by heat cured conventional technique of polymethylmethacrylate
Study NCT05990088 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: CAD/CAM Milled Methacrylate Complete Removable Dentures based on neutral zone concept.
Description: The patients will receive complete removable dentures designed based on the neutral-zone concept and digitally manufactured using a milling machineز
Study NCT06238609 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Control Group
Description: Subjects will receive a non-functional neuromodulation device to wear for 1 hour daily up to four weeks or until hospital discharge, whichever came first.
Study NCT05113550 — intervention group
Intervention type: OTHER
Intervention: Surgical remove
Description: liver hydatid cyst (LHC) treated by total or partial pericystectomy
Study NCT04938180 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AMB-05X
Description: AMB-05X is a fully human antibody antagonist (immunoglobulin G, type 2 \[IgG2\]) specific to the extracellular domain of human CSF1R
Study NCT04848051 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CRC screening reminder
Description: Participants randomized to the CRC Reminder arm will receive reminder that they are due/overdue for CRC screening
Study NCT04848051 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CRC Reminder & Short message
Description: Participants randomized to the CRC Reminder \& short message arm will receive reminder that they are due/overdue for CRC screening and short message to encourage screening
Study NCT04848051 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CRC Reminder and Navigation Program
Description: Participants randomized to the CRC reminder and navigation program arm will receive reminder that they are due/overdue for CRC screening and short message to participate in the health navigation program that will connect participants to individually tailored resources and assistance
Study NCT04848051 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CRC Reminder & CRC education
Description: Participants randomized to the CRC reminder and CRC education program arm will receive reminder that they are due/overdue for CRC screening and offered short educational program conducted online
Study NCT05970523 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Core Stabilization Exercises
Description: Core stabilization exercises are known as a very effective exercise method based on the motor learning principle, performed with the individual's own body weight to strengthen the muscles, improve balance, posture, trunk muscle endurance and flexibility.Each exercise was performed for 7-8 seconds with 10 repetitions. Progression in the exercises was achieved by increasing the difficulty level of the exercises according to the participant's condition once every two weeks.
Study NCT06008795 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pterygopalatine Fossa Nerve Block with Ropivacaine and Dexamethasone
Description: Each PPF-active nerve block will consist of 20mg (4ml) ropivacaine plus 4mg (1ml) dexamethasone
Study NCT06008795 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Pterygopalatine Fossa Nerve Block with Ropivacaine and Dexamethasone
Description: Each PPF-active nerve block will consist of 20mg (4ml) ropivacaine plus 4mg (1ml) dexamethasone
Study NCT06008795 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Placebo Pteryogpalatine Fossa Injection
Description: Each placebo PPF-injection will consist of 5ml normal saline
Study NCT06008795 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Pteryogpalatine Fossa Injection
Description: Each placebo PPF-injection will consist of 5ml normal saline
Study NCT04980521 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Print brochure
Description: Participants will receive print brochures.
Study NCT05648422 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Probiotics
Description: Saccharomyces Boulardii 200 mg every 12 hours for 6 days at week 1, 5 and 9
Study NCT05648422 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: NSS Nutritional Support System
Description: Nutritional Support System consists in NSS envelope (glutamine, arginine, folic acid, PUFA-n3, vegetal protein, nicotinic acid, cobalamin, thiamine, pyridoxine, magnesium, zinc, selenium, cholecalciferol, resveratrol, ascorbic acid, Spirulina Máxima, glycine, tryptophan, and inuline) every 12 hours for 12 weeks.
Study NCT05648422 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Deworming
Description: nitazoxanide at a dosage of 7.5 mg / kg every 12 hours for 3 days
Study NCT05648422 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Specific diet
Description: This diet focuses on meeting caloric needs according to age, weight, height, and stress factor dividing total caloric value in 50% carbohydrates, 30% lipids, and 20% proteins. It consists of smoothies at breakfast and dinner, high consumption of fish, five meals during the day, 70% of meals eaten during the day will consist on vegetables, fruits, roots, cereals, and legumes. Red meat, gluten, lactose, junk food, sugar, salt, fast food free.
Study NCT05648422 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional diet (WHO)
Description: This diet focuses on meeting caloric needs according to age, weight, height, and stress factor dividing total caloric value in 50% carbohydrates, 30% lipids, and 20% proteins. It consists of general nutricional recommendations.
Study NCT05376774 — intervention group
Intervention type: OTHER
Intervention: Admitted to intensive care units
Description: Admitted to intensive care units
Study NCT05579353 — intervention group
Intervention type: OTHER
Intervention: nothing
Description: nothing
Study NCT06578208 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Spinal Manipulation
Description: The patient was placed in the lateral decubitus position by the therapist. The foot was placed on the popliteal fossa of the lower leg while the upper knee was flexed. Once the patient was in this position, the therapist performed high velocity and low amplitude thrusts (HVLA; high velocity - low amplitude) on the vertebra with dysfunction (Fagundes Loss et al., 2020).
Study NCT06275204 — intervention group
Intervention type: DRUG
Intervention: Bismuth-based quadruple therapy
Description: Participants who are positive with H. pylori will receive bismuth-based quadruple therapy:~Antibiotic 1 - Amoxicillin 4 x 500 mg or Clarithromycin 2 x 400 mg, Antibiotic 2 - Metronidazole 4 x 400 mg, Proton pump inhibitor - Esomeprazole 2 x 40 mg, Colloidal bismuth - Bismuth oxide 4 x 120 mg.
Study NCT06275204 — intervention group
Intervention type: DRUG
Intervention: Levofloxacin-based quadruple therapy
Description: In case there will be a treatment failure after Protocol I is completed, the remaining patients with a positive infection will be referred to a secondary treatment:~Antibiotic 1 - Levofloxacin 1 x 500 mg, Antibiotic 2 - Metronidazole 4 x 400 mg, Proton pump inhibitor - Esomeprazole 2 x 40 mg, Colloidal bismuth - Bismuth oxide 4 x 120 mg.
Study NCT06336902 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Balstilimab
Description: Given IV
Study NCT06275204 — intervention group
Intervention type: DRUG
Intervention: Standard triple therapy
Description: Participants who are positive for H. pylori will receive a standard triple therapy:~Antibiotic 1 - Amoxicillin 2 x 1000 mg, Antibiotic 2 - Clarithromycin 2 x 500 mg, Proton pump inhibitor - Esomeprazole 2 x 40 mg.
Study NCT06275204 — intervention group
Intervention type: DRUG
Intervention: Levofloxacin-based triple
Description: Participants with treatment failure will be recommended second line treatment - levofloxacin-based:~Antibiotic 1 - Levofloxacin 2 x 500 mg, Antibiotic 2 - Amoxicillin 2 x 1000 mg, Proton pump inhibitor - Esomeprazole 2 x 40 mg
Study NCT05208073 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cosmetic therapy
Description: The cosmetic therapy in this study is once a week, 60 minutes each section for a total of 6-week. Cosmetic therapy uses the teaching materials to teach the subjects skincare and makeup operation steps and use the 10-minute limb stretching to relax their minds before the activity, and then lead the research subjects to use cotton pads to apply lotion and lotion. , female subjects used powder, eyebrow pencil, and lipstick (or lip balm) to complete weekly different-themed activities and hairstyling, while men performed weekly different theme activities and hairstyling.
Study NCT06204549 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Screening and management of cormobidities
Description: During the routine care assessment and as part of the research, patients will :~* Fill in cardiovascular risk assessment score: Life's simple 7~* Provide an additional blood sample (1 dry tube of 7 mL and 1 heparin tube of 7 mL) during their biological testing. These samples will be used for lipoprotein (a) testing and biological collection.~After hospital discharge, patients will be contacted by telephone at 3 and 12 months for re-evaluation and will fill in the Life's simple 7 score. Prior to this contact, patients will have biological tests as prescribed just before hospital discharge (including blood ionogram, creatinine, liver assessment, lipid assessment (LDL, HDL, triglycerides), fasting blood sugar test, A1C test, urinary albumin/creatinine ratio, protein/ urinary creatinine ratio). They will weigh themselves and take blood pressure self-measurements over 3 days.
Study NCT06336902 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT06216457 — intervention group
Intervention type: DEVICE
Intervention: AI software for Stroke
Description: AI Software for Non-Contrast Head CT (Computed Tomography) and CT Angiography, utilized for Code Stroke screening, notification and triage.
Study NCT06336902 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Botensilimab
Description: Given IV
Study NCT06336902 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT scan
Study NCT06336902 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dietary Intervention
Description: Undergo FMD
Study NCT06336902 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT06336902 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin C
Description: Given IV
Study NCT06568822 — intervention group
Intervention type: OTHER
Intervention: Asessment
Description: Data prepared by researchers regarding the general characteristics of older adults will be examined.
Study NCT06568822 — intervention group
Intervention type: OTHER
Intervention: The Physical Activity Scale for the Elderly (PASE)
Description: PASE will be used to assess the physical activity levels of older adults.
Study NCT06568822 — intervention group
Intervention type: OTHER
Intervention: Turkish Version of the Satisfaction with Life Scale (T-SWLS)
Description: T-SWLS will be used to assess life satisfaction of older adults.
Study NCT06568822 — intervention group
Intervention type: OTHER
Intervention: Modified Morisky Scale (MMS)
Description: MMS will be used to evaluate medication adherence in older adults.
Study NCT06575257 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Darolutamide
Description: 600 mg orally twice daily for 12 weeks before radical prostatectomy
Study NCT06575257 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Goserelin 3.6 mg
Description: 3.6 mg goserelin hypodermic once per 4 weeks
Study NCT04806893 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: lerodalcibep
Description: 300 mg subcutaneous injection every month (Q4W)
Study NCT04806893 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: matching subcutaneous injection every month (Q4W)
Study NCT05887440 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: isokinetic strength training of knee extensor and flexor muscles
Description: Patients underwent an isokinetic strength training program with 3 sessions per week during five weeks.~Program consists of excentric contraction of knee flexor and extensor muscles (4 x 7 Contractions at 30°/s) and concentric contractions at maximal speed where patients can perform 40% of his maximal isometric torque for knee flexor and extensor muscles (2x10 for knee flexors and 2x10 for knee extensors)
Study NCT06530823 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemigatinib and Durvalumab
Description: Pemigatinib combined with Durvalumab Pemigatinib: 13.5mg, oral administration, once daily, swallow the entire tablet with or without food. Take for 2 weeks and then discontinue for 1 week. Durvalumab: 1500mg, intravenous infusion, once every three weeks. Each infusion should take over 60 minutes.
Study NCT05634538 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Robotic-assisted PCI with Corpath GRX® System
Description: The CorPath GRX System is intended for use in the remote delivery and manipulation of guidewires and rapid exchange catheters, and remote manipulation of guide catheters during percutaneous coronary interventions (PCI).
Study NCT05634538 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard PCI
Description: Percutaneous coronary intervention (PCI) is a procedure used to treat the blockages in a coronary artery; it opens up narrowed or blocked sections of the artery, restoring blood flow to the heart. This arm will be completed without robotic assistance.
Study NCT05991752 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: ROMA score evaluation
Description: Every 4 months, for 3 years, patients in the experimental group will done a biological examination based on assessment of the ROMA score (CA125+HE4 assay).
Study NCT06176963 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: SB11 PFS
Description: SB11 provided in a pre-filled syringe (PFS) containing 0.5 mg ranibizumab in 0.05 mL for ITV injection
Study NCT04790318 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Trans-incisional Quadratus lumborum block
Description: patients will receive combined general anesthesia and quadratus lumborum block (trans-incisional) with 0.5 mL/kg of bupivacaine 0.2 %. with maximum volume was limited to 20 ml
Study NCT04790318 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Caudal block
Description: patients will receive combined general anesthesia and caudal analgesia (just after wound closure) with 1.25 mL/kg of bupivacaine 0.2 % (three parts 0.25 % bupivacaine to one part saline.
Study NCT06164119 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: manual treatment with osteopathic techniques and nutritional treatment
Description: manual treatment with osteopathic techniques (8 once-a-week manual treatments with osteopathic techniques) and nutritional treatment (personalized Mediterranean Diet)
Study NCT06164119 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: manual treatment with osteopathic techniques
Description: manual treatment with osteopathic techniques (8 once-a-week manual treatments with osteopathic techniques)
Study NCT06164119 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: nutritional treatment
Description: nutritional treatment (personalized Mediterranean Diet)
Study NCT05018871 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: autologous adipose derived mesenchymal stem cells
Description: cultured autologous adult adipose derived mesenchymal stem cells
Study NCT05267249 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Autotransplantation and Apicoectomy
Description: Autotransplantation of a mature teeth with simultaneous extra-oral root-end resectoin
Study NCT05809232 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: CARES-guided Group
Description: Participants randomised to the CARES-guided arm will have their CARES-score calculated and entered into the Pre-Anesthesia Assessment electronic form within the Electronic Medical Records (EMR). This score and its relevant advisories will be prominently displayed on this electronic form. (Participants on this arm will receive this intervention in addition to the routine practice).
Study NCT05730361 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ScTIL injection
Description: Peripheral blood mononuclear cells (PBMCs) obtained via apheresis are used for cell preparation. PD-1 positive T cells are isolated from PBMCs, are transduced with lentivirus loaded with enhanced receptor and superamplification factor, and cell number are amplified. The obtained ScTIL is used for one-time intravenous infusion.
Study NCT05730361 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ScTIL injection and B lymphocytes adjuvant
Description: B lymphocyte are also isolated from PBMCs. If the percentage of subject's B lymphocyte in total lymphocytes is > 5%, the autologous B lymphocyte adjuvant will be prepared. If this percentage is ≤ 5%, PBMCs will be collected from haploidentical donor of the subject via apheresis, and B lymphocyte will be isolated for preparation of allogeneic B lymphocyte adjuvant.
Study NCT05312775 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Double-layer uterine closure
Description: In the intervention group, double-layer closure of the uterus will be performed using unlocked multifilament continuous running sutures for both layers and the endometrial layer will be included in the first layer. The second layer is a continuous running suture that imbricates the first layer
Study NCT05312775 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Single-layer uterine closure
Description: The control group will receive a single-layer closure using unlocked continuous running multifilament sutures and the endometrial layer will be included